Beam Therapeutics Inc (NAS:BEAM)

$ 27.08 0.72 (2.73%) Market Cap: 2.24 Bil Enterprise Value: 1.42 Bil PE Ratio: 0 PB Ratio: 2.82 GF Score: 54/100

Q3 2024 Beam Therapeutics Inc Earnings Call Transcript
Nov 05, 2024

$23.93 (-1.77%)

Earnings
Beam Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Jan 08, 2024
Beam Therapeutics Inc at Citi BioPharma Conference Transcript
Sep 07, 2023
Beam Therapeutics Inc at Stifel Tailoring Genes: Genetic Medicines Day (Virtual) Transcript
May 30, 2023
Beam Therapeutics Inc at Barclays Virtual Gene Editing & Therapy Summit Transcript
May 24, 2023
Beam Therapeutics Inc at RBC Capital Markets Global Healthcare Conference Transcript
May 17, 2023
Beam Therapeutics Inc at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days (Virtual) Transcript
Apr 03, 2023
Beam Therapeutics Inc at Barclays Global Healthcare Conference Transcript
Mar 16, 2023
Beam Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Jan 09, 2023
Beam Therapeutics Inc at Bank of America Biotech SMID Cap Conference Transcript
Dec 07, 2022
Beam Therapeutics Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript
Dec 01, 2022
Beam Therapeutics Inc at Jefferies London Healthcare Conference Transcript
Nov 15, 2022
Beam Therapeutics Inc Annual Shareholders Meeting Transcript
Jun 08, 2022
Beam Therapeutics Inc at RBC Capital Markets Global Healthcare Conference Transcript
May 17, 2022
Beam Therapeutics Inc at Bank of America Healthcare Conference Transcript
May 11, 2022
Beam Therapeutics Inc at Barclays Global Healthcare Conference Transcript
Mar 15, 2022
Beam Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 10, 2022
Beam Therapeutics Inc at Jefferies Gene Therapy/Editing Summit (Virtual) Transcript
Oct 27, 2021
Beam Therapeutics Inc at Chardan Genetic Medicines Conference (Virtual) Transcript
Oct 05, 2021
Beam Therapeutics Inc at William Blair Biotech Focus Conference (Virtual) Transcript
Jul 15, 2021
Beam Therapeutics Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Mar 11, 2021
Beam Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 12, 2021

Beam Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2021 / 04:40PM GMT

Release Date Price: $97.06 (+3.17%)

Transcript

Eric William Joseph

JPMorgan Chase & Co, Research Division - VP & Senior Analyst

All right. Thanks again for joining us at our health care conference. I'm Eric Joseph, senior biotech analyst at JPMorgan. And our next presenting company is Beam Therapeutics. And it's my pleasure to welcome John Evans, CEO, to tell us a little bit about the company. Before I hand it over for the presentation, I just want to note that there is a Q&A after the presentation. (Operator Instructions)

With that, John, thanks again for joining us today.

John M. Evans

Beam Therapeutics Inc. - CEO & Director

All right. Thank you, Eric. Hello, everybody. Great to be here today. Sorry, not to be in-person San Francisco, but nonetheless excited to be entering the new year, 2021. Okay. So I'm going to walk you through a little bit about Beam today. I'll be referring to the slides, which I know you have access to as well. And Beam is really trying to create a new class of precision genetic medicines using base editing, and I'm going to tell you about that technology

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.